ST. LOUIS, Mo., Dec. 05, 2025 (GLOBE NEWSWIRE) — Wugen, Inc., a clinical-stage U.S. biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of hematological malignancies, today announced an upcoming scientific presentation of the company's Phase 1/2 study of WU-CART-007 (Soficabtagene Geleucel “Sofi-cel”). Researchers will present Phase 1/2 correlative data and long-term follow-up update […]

Perpetua brings additional expertise and depth of experience to manage and deliver the Stibnite Gold Project Perpetua Resources Corp. (Nasdaq: PPTA / TSX: PPTA) (“Perpetua Resources” or “Perpetua” or the “Company”) today announced key additions to the Company's leadership team, bringing on accomplished industry leaders as the Company continues Early Works construction of the Stibnite

— 62.5% increase in revenue generating headcount from previously announced 24 on October 29, 2025. — Approximately 704% increase in annualized program billings on government services over FY2024 billings of $1M1. — Approximately 845% increase in annualized gross margin contribution from government services of approximately $2.3M2 over FY2024 gross margin of $0.2M3. DEFSEC Technologies Inc.

Transaction Unites Warner Bros.' Iconic Franchises and Storied Libraries with Netflix'sLeading Entertainment Service, Creating an Extraordinary Offering for Consumers Netflix to Maintain Warner Bros.' Current Operations Combination Will Offer More Choice and Greater Value for Consumers, Create More Opportunities for the Creative Community and Generate Shareholder Value Acquisition Will Strengthen the Entertainment Industry Today, Netflix,

Enter to win $1,000 and a pair ofFitVille shoes as you share your dream holiday travels. As the holiday season approaches, FitVille is excited to launch its “Christmas Travels, FitVille Gifts” event, giving two lucky winners the chance to receive $1,000 in cash and a brand-new pair of FitVille shoes. If you're planning Christmas travels

Project at Incheon International Airport, South Korea, recognized by Elevator World Elevator World magazine has selected anOtis Worldwide Corporation (NYSE: OTIS) project as a winner in its annual Project of the Year awards – recognizing its deep expertise and experience serving airports and major infrastructure projects. https://mma.prnewswire.com/media/2838705/Otis_Worldwide_Incheon_International_Airport_Award.jpg The Incheon International Airport project received the honor

Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Durable Glycemic and C-Peptide Improvements with Icovamenib in Insulin-Deficient Type 2 Diabetes GlobeNewswire December 05, 2025 SAN CARLOS, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq:

NobleAI Appoints Alex Wang as Chief Executive Officer to Lead Next Phase of Growth and Innovation Former VMware strategy leader to guide NobleAI's Science-Based AI platform through its next phase of growth in chemistry and energy innovation GlobeNewswire December 05, 2025 SAN FRANCISCO, Dec. 05, 2025 (GLOBE NEWSWIRE) — NobleAI, the leader in practical AI

Ocular Therapeutix(TM) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 05, 2025 BEDFORD, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to eight newly hired non-executive employees. The awards were

Iridex to Present at the Sidoti Year-End Virtual Investor Conference GlobeNewswire December 05, 2025 MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to participate in